Bjarke M. Klein

3.2k total citations · 1 hit paper
35 papers, 1.9k citations indexed

About

Bjarke M. Klein is a scholar working on Reproductive Medicine, Public Health, Environmental and Occupational Health and Urology. According to data from OpenAlex, Bjarke M. Klein has authored 35 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Reproductive Medicine, 16 papers in Public Health, Environmental and Occupational Health and 6 papers in Urology. Recurrent topics in Bjarke M. Klein's work include Ovarian function and disorders (16 papers), Reproductive Biology and Fertility (14 papers) and Sperm and Testicular Function (5 papers). Bjarke M. Klein is often cited by papers focused on Ovarian function and disorders (16 papers), Reproductive Biology and Fertility (14 papers) and Sperm and Testicular Function (5 papers). Bjarke M. Klein collaborates with scholars based in Denmark, Belgium and Spain. Bjarke M. Klein's co-authors include Karen A. Krogfelt, Joan‐Carles Arce, Bo Jørgensen, Tonny Karlsmark, Jens Jørgen Christensen, Jens Peter Nørgaard, Jeffrey P. Weiss, Anders Nyboe Andersen, Andreas Reisner and Søren Molin and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Bacteriology and The Journal of Urology.

In The Last Decade

Bjarke M. Klein

33 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Multiple bacterial species reside in chronic wounds: a longitudinal study

2006 484 citations Jens Jørgen Christensen, Tonny Karlsmark et al. International Wound Journal profile →

Peers

Countries citing papers authored by Bjarke M. Klein

Since Specialization

Citations

This map shows the geographic impact of Bjarke M. Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bjarke M. Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bjarke M. Klein more than expected).

Fields of papers citing papers by Bjarke M. Klein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bjarke M. Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bjarke M. Klein. The network helps show where Bjarke M. Klein may publish in the future.

Co-authorship network of co-authors of Bjarke M. Klein

This figure shows the co-authorship network connecting the top 25 collaborators of Bjarke M. Klein. A scholar is included among the top collaborators of Bjarke M. Klein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bjarke M. Klein. Bjarke M. Klein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical outcomes of potential high responders after individualized FSH dosing based on anti-Müllerian hormone and body weight 2021 ·Reproductive BioMedicine Online ·Hana Višňová, Enrico Papaleo, (unknown), Katarzyna Kozioł, Bjarke M. Klein, Bernadette Mannaerts	8
2	Individualization of the starting dose of follitropin delta reduces the overall OHSS risk and/or the need for additional preventive interventions: cumulative data over three stimulation cycles 2018 ·Reproductive BioMedicine Online ·Manuel Fernández Sánchez, Hana Višňová, Albert Yuzpe, Bjarke M. Klein, Bernadette Mannaerts, Joan‐Carles Arce	27
3	Follitropin delta in repeated ovarian stimulation for IVF: a controlled, assessor-blind Phase 3 safety trial 2018 ·Reproductive BioMedicine Online ·Ernesto Bosch, Jon Havelock, (unknown), (unknown), Bjarke M. Klein, Bernadette Mannaerts, Joan‐Carles Arce	32
4	Metformin in type 1 diabetes: methods and baseline characteristics of the REMOVAL trial 2016 ·UCL Discovery (University College London) ·(unknown), Nish Chaturvedi, Ian Ford, Irene Hramiak, Alun D. Hughes, (unknown), Bjarke M. Klein, (unknown), (unknown), Peter Rossing, Naveed Sattar, Coen D.A. Stehouwer, Helen M. Colhoun	1
5	Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials 2015 ·Fertility and Sterility ·Scott M. Nelson, Bjarke M. Klein, Joan‐Carles Arce	92
6	Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimüllerian hormone–stratified, dose–response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection 2014 ·Fertility and Sterility ·Joan‐Carles Arce, Anders Nyboe Andersen, Manuel Fernández Sánchez, Hana Višňová, Ernesto Bosch, Juan A. García-Velasco, Pedro N. Barri, Petra De Sutter, Bjarke M. Klein, Bart C.J.M. Fauser	127
7	The rate of high ovarian response in women identified at risk by a high serum AMH level is influenced by the type of gonadotropin 2014 ·Gynecological Endocrinology ·(unknown), Bjarke M. Klein, Antonio La Marca	15
8	Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients 2013 ·Fertility and Sterility ·(unknown), Antonio La Marca, Bjarke M. Klein, Anders Nyboe Andersen, Richard Fleming	134
9	Endometrial quality at the end of controlled ovarian stimulation predicts ongoing pregnancy rate after transfer of a single expanded or hatching/hatched blastocyst on day 5 in a fresh cycle 2012 ·Fertility and Sterility ·Roger A. Pierson, M Mrázek, (unknown), Bjarke M. Klein, Joan‐Carles Arce	1
10	The value of anti-Mullerian hormone measurement in the long GnRH agonist protocol: association with ovarian response and gonadotrophin-dose adjustments 2012 ·Human Reproduction ·Ellen Anckaert, Johan Smitz, Johan Schiettecatte, Bjarke M. Klein, Joan‐Carles Arce	77
11	Long‐term durability of the response to desmopressin in female and male nocturia patients 2012 ·Neurourology and Urodynamics ·Kristian Vinter Juul, Bjarke M. Klein, Jens Peter Nørgaard	23
12	No need for biopsies: comparison of three sample techniques for wound microbiota determination 2011 ·International Wound Journal ·(unknown), Mette E. Skindersoe, Jens Jørgen Christensen, Tonny Karlsmark, Bo Jørgensen, (unknown), Bjarke M. Klein, (unknown), Karen A. Krogfelt	39
13	The role of Campylobacter jejuni cytolethal distending toxin in gastroenteritis: toxin detection, antibody production, and clinical outcome 2011 ·Apmis ·Ninell P. Mortensen, Peter Schiellerup, Nadia Boisen, Bjarke M. Klein, Henning Locht, Manal AbuOun, Diane G. Newell, Karen A. Krogfelt	22
14	Long-term desmopressin response in primary nocturnal enuresis: open-label, multinational study 2008 ·International Journal of Clinical Practice ·H. Lottmann, Lola Baydala, Paul Eggert, Bjarke M. Klein, Jonathan Evans, (unknown)	26
15	Development and validation of an ATP method for rapid estimation of viable units in lyophilised BCG Danish 1331 vaccine 2008 ·Biologicals ·(unknown), (unknown), Bjarke M. Klein, K Hasløv	20
16	La surveillance des données d’envois des ambulances comme instrument pour l’alerte rapide 2006 ·Eurosurveillance ·(unknown), Bjarke M. Klein, Kåre Mølbak, Sven Trautner, (unknown), Erik D. Heegaard	1
17	Multiple bacterial species reside in chronic wounds: a longitudinal study breakdown → 2006 ·International Wound Journal ·(unknown), Jens Jørgen Christensen, Tonny Karlsmark, Bo Jørgensen, Bjarke M. Klein, Karen A. Krogfelt	484
18	Levamisole Inhibits Angiogenesis in vitro and Tumor Growth in vivo 2005 ·Angiogenesis ·T Friis, (unknown), Bjarke M. Klein, Jørgen Rygaard, Gunnar Houen	23
19	Increase and change in pattern of hospital antimicrobial use, Denmark, 1997–2001 2004 ·Journal of Antimicrobial Chemotherapy ·Berit Müller‐Pebody, Mark Muscat, Benjamin Pelle, Bjarke M. Klein, Christian Brandt, Dominique L. Monnet	41
20	Cumulative side effects of cyclosporine and Ca antagonists: hypergalactinemia, mastadenoma, and gynecomastia. 1994 ·PubMed ·(unknown), Bjarke M. Klein, H. U. Klehr	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact